Results 131 to 140 of about 1,964,079 (337)

Tall Cell Variant of Papillary Breast Carcinoma

open access: yes, 2018
Tall cell variant of papillary carcinoma is a unique special type of primary breast neoplasm not related to a thyroid gland neoplasm, showing very frequently a triple-negative profile, but low aggressive potential and a good ...
Francesca Ambrosi   +3 more
core   +1 more source

Patient therapy outcome modeling in cancer organoids is improved by cancer‐associated fibroblasts and organoid assembly convolution

open access: yesMolecular Oncology, EarlyView.
Patient‐derived organoids (PDOs) from pancreatic, colorectal, and gastric cancers were used to evaluate standard and experimental therapies. Incorporating cancer‐associated fibroblasts (CAFs) into organoid cultures improved patient therapy outcome prediction.
Marcin Grochowski   +12 more
wiley   +1 more source

Isolated post-transplantation lymphoproliferative disease involving the breast and axilla as peripheral T-cell lymphoma

open access: yes, 2018
Breast; Breast lymphoma; Breast neoplasm; Breast US; Post-transplantation lymphoproliferative ...
이지은, 차은숙, 성순희
core   +1 more source

Comparison between core needle biopsy and excisional biopsy for breast neoplasm. [PDF]

open access: yesMedicine (Baltimore), 2021
Sun C   +8 more
europepmc   +1 more source

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

open access: yesMolecular Oncology, EarlyView.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim   +3 more
wiley   +1 more source

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

open access: yesMolecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller   +10 more
wiley   +1 more source

Tubular Adenoma of the Breast: A Clinicopathologic Study of a Series of 9 Cases

open access: yesClinical Medicine Insights: Pathology, 2018
Tubular adenoma of the breast is one of the most rare benign neoplasms, accounting for only 0.13% to 1.7% of all breast benign tumors. Little is known about this rare neoplasm as the current literature offers only some case reports or a few number of ...
Boubacar Efared   +5 more
doaj   +1 more source

ZW4864‐mediated inhibition of the β‐catenin/BCL9/BCL9L complex reveals therapeutic potential in bladder cancer

open access: yesMolecular Oncology, EarlyView.
BCL9 and BCL9L drive bladder cancer progression by enhancing β‐catenin signaling, promoting proliferation, migration, invasion, and organoid growth. Genetic depletion of BCL9(L) suppresses malignant phenotypes, while pharmacological disruption of the β‐catenin/BCL9(L) complex with ZW4864 inhibits canonical Wnt signaling and tumor‐associated cellular ...
Roland Kotolloshi   +11 more
wiley   +1 more source

Metaplastic carcinoma of the breast – Case report and review of literature

open access: yes, 2020
Metaplastic carcinoma is an uncommon neoplasm of breast, accounting for about 1% of breast carcinomas [1]. It's presentation is similar to other type of breast cancers clinically as well as radiologically but it is associated with rapid growth ...
Kumar, Manoj   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy